ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 yea...

Related Keywords

Germany ,Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Australia ,Amitd Munshi ,America Ph ,Paul Perreault ,Aventis Bioservices ,Emily Brabbit ,Aventis Behring ,University Of Central Florida ,Board Of Directors The Pharmaceutical Research ,Wharton School Of The University Pennsylvania ,Kellogg School Of Management ,Chief Executive Officer ,Managing Director ,North America ,Pharmaceutical Research ,Harvard Business Review ,Central Florida ,Kellogg School ,Wharton School ,Argot Partners ,